184 related articles for article (PubMed ID: 7250872)
1. [Drug testing today].
Domschke S; Domschke W
Fortschr Med; 1981 Jun; 99(21):814-8. PubMed ID: 7250872
[TBL] [Abstract][Full Text] [Related]
2. From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials.
Heemskerk J; Tobin AJ; Ravina B
Nat Neurosci; 2002 Nov; 5 Suppl():1027-9. PubMed ID: 12403977
[No Abstract] [Full Text] [Related]
3. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
4. A phased approach to clinical testing: criteria for progressing from Phase I to Phase II to Phase III studies.
André FE; Foulkes MA
Dev Biol Stand; 1998; 95():57-60. PubMed ID: 9855414
[TBL] [Abstract][Full Text] [Related]
5. Drug research: from the idea to the product.
Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
[TBL] [Abstract][Full Text] [Related]
6. Legal requirements for drug testing in children in Germany.
Hasskarl H
Pediatr Pharmacol (New York); 1983; 3(3-4):361-6. PubMed ID: 6677882
[TBL] [Abstract][Full Text] [Related]
7. The principles of controlled clinical trials of drugs.
Herman ZS
Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):361-4. PubMed ID: 357309
[TBL] [Abstract][Full Text] [Related]
8. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
9. Toxicogenomics in drug discovery: from preclinical studies to clinical trials.
Yang Y; Blomme EA; Waring JF
Chem Biol Interact; 2004 Nov; 150(1):71-85. PubMed ID: 15522262
[TBL] [Abstract][Full Text] [Related]
10. [Responsibilities of clinical pharmacology in the early phase of drug development].
Kuhlmann J
Med Klin (Munich); 2000 May; 95(1 Spec No):31-40. PubMed ID: 10851846
[TBL] [Abstract][Full Text] [Related]
11. Changing requirements for evaluation of pharmacologic agents.
Chesney RW; Christensen ML
Pediatrics; 2004 Apr; 113(4 Suppl):1128-32. PubMed ID: 15060209
[TBL] [Abstract][Full Text] [Related]
12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
13. The future of drug safety testing: expanding the view and narrowing the focus.
Stevens JL; Baker TK
Drug Discov Today; 2009 Feb; 14(3-4):162-7. PubMed ID: 19100337
[TBL] [Abstract][Full Text] [Related]
14. [Placebos and double-blind studies: significant differences].
Schelling JL
Rev Med Suisse Romande; 1969 Sep; 89(9):905-9. PubMed ID: 4921157
[No Abstract] [Full Text] [Related]
15. Limitations of dose tolerance studies on predictability for phase III.
Warrington SJ
Arzneimittelforschung; 1985; 35(5):781-3. PubMed ID: 4026898
[TBL] [Abstract][Full Text] [Related]
16. [Clinical trials of drugs without immediate therapeutic objectives].
Cheymol G
Ann Med Interne (Paris); 1987; 138(3):173-7. PubMed ID: 3619247
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial design in metastatic breast cancer: a commentary.
Levine M
Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib for the treatment of advanced renal cell carcinoma.
Kane RC; Farrell AT; Saber H; Tang S; Williams G; Jee JM; Liang C; Booth B; Chidambaram N; Morse D; Sridhara R; Garvey P; Justice R; Pazdur R
Clin Cancer Res; 2006 Dec; 12(24):7271-8. PubMed ID: 17189398
[TBL] [Abstract][Full Text] [Related]
19. [Principles of controlled trials (author's transl)].
Fink H
Arzneimittelforschung; 1978; 28(11a):2017-9. PubMed ID: 383091
[TBL] [Abstract][Full Text] [Related]
20. [Should the pharmaceutical industry play an active part in pharmacosurveillance? (author's transl)].
d'Azemar P; Alexandre C; Thomas J
Anesth Analg (Paris); 1980; 37(9-10):537-42. PubMed ID: 7469070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
